Author Search Results

1

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells

by Penichon J, Decoville T, Holl V, Delaporte M, Moog C
Published 2009-10-01

Article

2

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection

by Moog C, Schmidt S, Decoville T, Penichon J, Lederle A, Holl V
Published 2009-10-01

Article

3

Anti-HIV and immune modulating activities of IND02

by Biedma ME, Connell B, Schmidt S, Lortat-Jacob H, Moog C, Prakash E
Published 2012-09-01

Article

4

P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes

by Aubertin A, Schmidt S, Decoville T, Peressin M, Holl V, Xu K, Moog C
Published 2009-10-01

Article

5

P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection

by Lopalco L, Reynes J, Moog C, Drillet A, Diomede L, Houimel M, Derrien M, Tudor D, Bomsel M
Published 2009-10-01

Article

6

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates

by Moog C, Dereuddre-Bosquet N, Biedma M, Schmidt S, Decoville T, Mangeot I, Zolla-Pazner S, Vcelar B, Katinger D, Holl V, Le Grand R
Published 2012-09-01

Article

7

P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group

by Polonis V, Osmanov S, Morris L, Moog C, Montefiori D, Malnati M, Lopalco L, Jansson M, Holmes H, Heyndrickx L, Heath A, Fenyö E, Bongertz V, Alcami J, Scarlatti G, Ramaswamy M, Sattentau Q, Schuitemaker H, Wrin T
Published 2009-10-01

Article

8

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

by Katinger D, Wagner A, Luque I, Crespillo S, Conejero-Lara F, Roger M, Martin C, Mouz N, Mourao S, Farsang A, Notka F, Malcolm K, Bosquet N, Le Grand R, Moog C, Cope A, Shattock R, Lewis DJ, El Habib R
Published 2012-09-01

Article

9

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort

by Bahram, S., Bastard, P., Bernard, A., Bibi-Triki, S., Carapito, C., Carapito, R., Casanova, J.-L, Chamaraux-Tran, T.-N, Chittenden, T.W, Collange, O., Danion, F., Drenou, B., Fafi-Kremer, S., Frappier, J., Gervais, A., Goichot, B., Guimaraes, R., Gujja, S., Gulcher, J.R, Hanauer, A., Hansmann, Y., Helms, J., Hermine, O., Hirschler, A., Javad Aman, M., Kailasan, S., Kuteifan, K., Larnicol, A., Laumond, G., Lederle, A., Li, R., Lidar, D., Macquin, C., Malagon-Lopez, J., Mariette, X., Mayeur, S., Mertes, P.-M, Meziani, F., Mohseninia, R., Molitor, A., Moog, C., Muller, L., Nilsson, P., Paul, N., Pichot, A., Pin, E., Pottecher, J., Radosavljevic, M., Rolli, V., Ruch, Y., Sanlaville, D., Schenck, M., Schmidt, S., Schneider, F., Sibilia, J., Simons, M., Spinnhirny, P., Stemmelen, T., Tahar, O., Tharaux, P.-L, Thomas, A., Viari, A., Wu, H., Zhang, Q.
Published 2022

View Fulltext in Publisher

Article

Related Subjects